138
Views
22
CrossRef citations to date
0
Altmetric
Original Research

pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-trans-retinoic acid and paclitaxel for cancer combination chemotherapy

, , , , , & show all
Pages 6499-6515 | Published online: 16 Oct 2018

References

  • HuQSunWWangCGuZRecent advances of cocktail chemotherapy by combination drug delivery systemsAdv Drug Deliv Rev201698193426546751
  • DepinhoRAThe age of cancerNature2000408680924825411089982
  • HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
  • BozicIReiterJGAllenBEvolutionary dynamics of cancer in response to targeted combination therapyElife20132e0074723805382
  • BangY-JVan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet2010376687697
  • VogusDREvansMAPusuluriAA hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancerJ Control Release201726719120228823957
  • ZhaoZLouSHuYZhuJZhangCA Nano-in-Nano Polymer-Dendrimer Nanoparticle-Based Nanosystem for Controlled Multidrug DeliveryMol Pharm20171482697271028704056
  • BushueNWanYJY-JyWRetinoid pathway and cancer therapeuticsAdv Drug Deliv Rev201062131285129820654663
  • OkunoMKojimaSMatsushima-NishiwakiRRetinoids in cancer chemopreventionCurr Cancer Drug Targets20044328529815134535
  • SuttonLMWarmuthMAPetrosWPWinerEPPharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trialCancer Chemother Pharmacol19974043353419225952
  • BryanMPulteEDToomeyKCA pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancerInvest New Drugs20112961482148720596747
  • ZuccariGBergamanteVCarosioRMicellar complexes of all-trans retinoic acid with polyvinylalcoholnicotinoyl esters as new parenteral formulations in neuroblastomaDrug Deliv200916418919519241235
  • HouLFanYYaoJLow molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acidCarbohydr Polym201186311571166
  • ChungKDJeongYIChungCWKimDHKangDHAnti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cellsInt J Pharm20124221–245446122093956
  • SunRLiuYLiSYCo-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cellsBiomaterials20153740541425453968
  • NiJTianFDahmaniFZCurcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugsDrug Deliv20162393424343527198856
  • CastleberrySAQuadirMASharkhMAShopsowitzKEHammondPTPolymer conjugated retinoids for controlled transder-mal deliveryJ Control Release20172621928690160
  • ZhangJHanJZhangXPolymeric nanoparticles based on chi-tooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxelCarbohydr Polym2015129253426050884
  • YaoJZhangLZhouJLiuHZhangQEfficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrierMol Pharm20131031080109123320642
  • LiJJiangXGuoYLinear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancerBioconjug Chem201526341842625675244
  • OhNMKwagDSOhKTElectrostatic charge conversion processes in engineered tumor-identifying polypeptides for targeted chemotherapyBiomaterials20123361884189322153865
  • HuoQZhuJNiuYpH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancerInt J Nanomedicine2017128631864729270012
  • FangYXueJGaoSCleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug deliveryDrug Deliv201724Supp 1223229069920
  • JinMJinGKangLSmart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomesInt J Nanomedicine2018132405242629719390
  • FangJNakamuraHMaedaHThe EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
  • ChoECXieJWurmPAXiaYUnderstanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchantNano Lett2009931080108419199477
  • FengSZhangHZhiCGaoXDNakanishiHpH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin deliveryInt J Nanomedicine20181364165229440891
  • duJZSunTMSongWJWuJWangJA tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug deliveryAngew Chem Int Ed Engl201049213621362620391548
  • WangYLvSDengMA charge-conversional intracellular-activated polymeric prodrug for tumor therapyPolym Chem201671222532263
  • ZhuJNiuYLiYStimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challengesJ Mater Chem B20175713391352
  • ChenWLLiFTangYStepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicinInt J Nanomedicine2017124241425628652730
  • FanBXingYZhengYpH-responsive thiolated chitosan nano-particles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluationDrug Deliv201623123824724865290
  • ZhouQZhangLYangTWuHStimuli-responsive polymeric micelles for drug delivery and cancer therapyInt J Nanomedicine2018132921294229849457
  • ShenYZhangJHaoWCopolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cellsInt J Nanomedicine20181353755329416334
  • TaghizadehBTaranejooSMonemianSAClassification of stimuli-responsive polymers as anticancer drug delivery systemsDrug Deliv201522214515524547737
  • ZhangJFangXLiZRedox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatolInt J Nanomedicine20181393995629491708
  • LinJZhaoCLiuCRedox-responsive F127-folate/F127-disulfide bond-d-〈-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumorsInt J Nanomedicine20181380583029445276
  • SunJLiuYChenYDoxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapyJ Control Release2017258435528501705
  • TanSWangGRedox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivoDrug Des Devel Ther20171135193529
  • LiJXuRLuXHeJJinSA simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistanceInt J Nanomedicine2017128043805629138561
  • SongQChuanXChenBA smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cellsDrug Deliv1734201523
  • ParkCWYangH-MWooM-ACompletely disintegrable redox-responsive poly(amino acid) nanogels for intracellular drug deliveryJournal of Industrial and Engineering Chemistry201745182188
  • AlaniAWBaeYRaoDAKwonGSPolymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxelBiomaterials20103171765177219959225
  • JiangYWangXLiuXEnhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted NanoparticlesACS Appl Mater Interfaces20179121121727976583
  • WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
  • YouYXuZChenYDoxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancerDrug Deliv201825144846029405790
  • YinXFengSChiYEstrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcomaDrug Deliv201825190090829644882
  • ZhangYLiPPanHRetinal-conjugated pH-sensitive micelles induce tumor senescence for boosting breast cancer chemotherapyBiomaterials20168321923226774567
  • HongGYJeongYILeeSJLeeEOhJSLeeHCCombination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinomaArch Pharm Res201134340741721547672
  • DuJZDuXJMaoCQWangJTailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug deliveryJ Am Chem Soc201113344175601756321985458
  • WuLWuMLinXMagnetite nanocluster and paclitaxel-loaded charge-switchable nanohybrids for MR imaging and chemotherapyJ Mater Chem B201754849857
  • YuanYYMaoCQduXJduJZWangFWangJSurface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumorAdv Mater201224405476548022886872
  • WuHCabralHTohKPolymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammationJ Control Release201418911024956488
  • BaoYGuoYZhuangXD-〈-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cellsMol Pharm20141193196320925102234
  • HouLYaoJZhouJZhangQPharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery systemBiomaterials201233215431544022521488